Comparison of Myelodysplastic Syndrome Prognostic Scoring Systems

@inproceedings{Bekta2016ComparisonOM,
  title={Comparison of Myelodysplastic Syndrome Prognostic Scoring Systems},
  author={{\"O}zlen Bektaş and Ayseg{\"u}l {\"U}ner and Eylem Eliaçık and B. Uz and Ayşe Işık and Sezgin Etg{\"u}l and S{\"u}reyya Bozkurt and Ibrahim Celalettin Haznedaroğlu and Hakan G{\"o}ker and Nilg{\"u}n Sayınalp and Salih Aksu and Hal{\^u}k Demiroǧlu and Osman İlhami {\"O}zcebe and Yahya B{\"u}y{\"u}kaşık},
  booktitle={Turkish journal of haematology : official journal of Turkish Society of Haematology},
  year={2016}
}
OBJECTIVE Myelodysplastic syndrome (MDS) is a clonal hematopoietic stem cell disease. Patients are at risk of developing cytopenias or progression to acute myeloid leukemia. Different classifications and prognostic scoring systems have been developed. The aim of this study was to compare the different prognostic scoring systems. MATERIALS AND METHODS One… CONTINUE READING